BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33179087)

  • 1. Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells.
    Cai J; Sun H; Zheng B; Xie M; Xu C; Zhang G; Huang X; Zhuang J
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.
    Zhang Y; Li H; Lv C; Wu B; Yu Y; Zhong C; Lang Q; Liang Z; Li Y; Shi Y; Zhang J; Xu F; Tian Y
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35920182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
    Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J
    J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H19/let‑7/Lin28 ceRNA network mediates autophagy inhibiting epithelial‑mesenchymal transition in breast cancer.
    Xiong H; Shen J; Chen Z; Yang J; Xie B; Jia Y; Jayasinghe U; Wang J; Zhao W; Xie S; Wang L; Zhou J
    Int J Oncol; 2020 Mar; 56(3):794-806. PubMed ID: 32124962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
    Hiscox S; Baruha B; Smith C; Bellerby R; Goddard L; Jordan N; Poghosyan Z; Nicholson RI; Barrett-Lee P; Gee J
    BMC Cancer; 2012 Oct; 12():458. PubMed ID: 23039365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
    Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
    Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
    Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer.
    Lee J; Kim EA; Kang J; Chae YS; Park HY; Kang B; Lee SJ; Lee IH; Park JY; Park NJ; Jung JH
    BMC Mol Cell Biol; 2024 Apr; 25(1):12. PubMed ID: 38649821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
    Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
    Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of long non‑coding RNA DDX11‑AS1 inhibits the proliferation, migration and paclitaxel resistance of breast cancer cells by upregulating microRNA‑497 expression.
    Liang M; Zhu B; Wang M; Jin J
    Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin decreases epithelial‑mesenchymal transition by a Pirin‑dependent mechanism in cervical cancer cells.
    Aedo-Aguilera V; Carrillo-Beltrán D; Calaf GM; Muñoz JP; Guerrero N; Osorio JC; Tapia JC; León O; Contreras HR; Aguayo F
    Oncol Rep; 2019 Nov; 42(5):2139-2148. PubMed ID: 31436299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells.
    Takeda T; Tsubaki M; Matsuda T; Kimura A; Jinushi M; Obana T; Takegami M; Nishida S
    Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35445730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.
    Loh YN; Hedditch EL; Baker LA; Jary E; Ward RL; Ford CE
    BMC Cancer; 2013 Apr; 13():174. PubMed ID: 23547709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer.
    Gan L; Lv L; Liao S
    Int J Oncol; 2019 Jun; 54(6):2157-2168. PubMed ID: 31081061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
    Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
    Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells.
    Moon SY; Lee H; Kim S; Hong JH; Chun SH; Lee HY; Kang K; Kim HS; Won HS; Ko YH
    BMC Cancer; 2021 Aug; 21(1):931. PubMed ID: 34407787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragalus polysaccharide inhibits breast cancer cell migration and invasion by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
    Yang S; Sun S; Xu W; Yu B; Wang G; Wang H
    Mol Med Rep; 2020 Apr; 21(4):1819-1832. PubMed ID: 32319619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA FEZF1‑AS1 promotes migration, invasion and epithelial‑mesenchymal transition of retinoblastoma cells by targeting miR‑1236‑3p.
    Zhang G; Yang W; Li D; Li X; Huang J; Huang R; Luo J
    Mol Med Rep; 2020 Nov; 22(5):3635-3644. PubMed ID: 32901841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.